Medical devices, healthcare technology and the business of care
COMPANY INTELLIGENCE

THERAKOS DEVELOPMENT LIMITED

Explore this company’s associated devices, FDA decisions and regulatory history.

Clinical monitoring equipment, editorial photography

THERAKOS DEVELOPMENT LIMITED

Regulatory records
1
Linked recall entries
1
Headquarters
Not reported
Brand website
Not reported
COMPANY INTELLIGENCE

What the linked records show

MedtechLedger currently links 1 FDA record to the applicant name THERAKOS DEVELOPMENT LIMITED. 1 entry is a PMA supplement. These are records held by this publication, rather than a count of the company’s entire portfolio.

The dated entries run from Nov 21, 2025 to Nov 21, 2025. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.

Product code LNR appears in 1 of the 1 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.

The largest PMA family in this collection is P860003, with 1 linked entry. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.

Applicant mailing address recorded by FDA: College Business & Technology Park, Cruiserath Rd., Dublin, D15 TX2V. Recorded on P860003/S112, decision dated Nov 21, 2025.

Changes described in PMA records

Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.

RECALL COVERAGE

Recalls linked to this firm

MedtechLedger links 1 FDA enforcement entry through the recorded recalling firm or an exact submission number published in FDA’s recall data. 1 Class II records are represented. Each row is an enforcement entry; one recall event can cover several product entries. These counts describe this collection and do not measure a manufacturer’s safety record or an injury rate.

Connections use the recorded recalling firm or the submission identifiers shown below. A shared submission connects the records; it does not establish that differently named legal applicants are interchangeable. Use the exact affected models, lots and instructions on each notice.

Source information

Source updated Nov 11, 2026. Retrieved Nov 21, 2026.

Regulatory record history

Product / regulatory recordCompanyPathwayDecision dateSource
THERAKOS DEVELOPMENT LIMITEDPMA supplementNov 21, 2025FDA
Source information

Source updated Nov 9, 2026. Retrieved Nov 21, 2026.